Crescendo Bioscience Revenue and Competitors
Estimated Revenue & Valuation
- Crescendo Bioscience's estimated annual revenue is currently $4.2M per year.
- Crescendo Bioscience's estimated revenue per employee is $77,500
- Crescendo Bioscience's total funding is $166.7M.
Employee Data
- Crescendo Bioscience has 54 Employees.
- Crescendo Bioscience grew their employee count by 4% last year.
Crescendo Bioscience's People
| Name | Title | Email/Phone |
|---|---|---|
1 | RA | Reveal Email/Phone |
Crescendo Bioscience Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Crescendo Bioscience?
Crescendo Bioscience is developing quantitative, objective molecular tests to provide rheumatologists with deeper clinical insights into biology, to help enable more effective management of patients with autoimmune and inflammatory diseases.
keywords:N/A
$166.7M
Total Funding
54
Number of Employees
$4.2M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Crescendo Bioscience News
Crescendo Bioscience Inc., Myriad Genetics Inc., and a whistleblower settled a False Claims Act suit alleging that the companies engaged in...
Crescendo Bioscience, Inc., No. 16-cv-2043 (N.D. Cal.). DOJ and the State of California declined to intervene, and the laboratory testing...
... on Friday that it has settled a qui tam, or whistleblower, lawsuit filed by STF against Myriad and its subsidiary Crescendo Bioscience.
Crescendo Bioscience was the fastest growing healthcare company. The 12-year-old molecular diagnostic company in San Francisco, which Myriad Genetics acquired last year, did an impressive sprint to its ranking of 7th this year compared with 67th last year. The company represents a convergence of ...
Molecular diagnostic company Myriad Genetics has acquired Crescendo Biosciences for $270 million, in cash, which included repayment of a $25 million loan that Myriad made to Crescendo in 2011. Investor Safeguard Scientifics has invested $11 million Crescendo Biosciences, giving it a 13 percent s ...
Other Companies in South San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $8.7M | 56 | 8% | N/A |
#2 | $11.6M | 57 | -10% | N/A |
#3 | $8.8M | 57 | 2% | N/A |
#4 | $4.6M | 59 | -11% | $237.8M |
#5 | $7.7M | 59 | -3% | N/A |